CONTACT

Tel / WhatsApp:
+86-18088661155

Technical Support:
jlchongming@conminbiotech.com

Address:
5th Floor, F8,Workshop 8, Science & Technology Incubation Park, Xinglong Comprehensive Bonded Zone, Changchun City, Jilin Province, China.

2019-nCoV/Flu A&B Nucleic Acid Test
2019-nCoV/Flu A&B Nucleic Acid Test
2019-nCoV/Flu A&B Nucleic Acid Test
2019-nCoV/Flu A&B Nucleic Acid Test
2019-nCoV/Flu A&B Nucleic Acid Test
2019-nCoV/Flu A&B Nucleic Acid Test
2019-nCoV/Flu A&B Nucleic Acid Test
2019-nCoV/Flu A&B Nucleic Acid Test
2019-nCoV/Flu A&B Nucleic Acid Test
2019-nCoV/Flu A&B Nucleic Acid Test
2019-nCoV/Flu A&B Nucleic Acid Test
2019-nCoV/Flu A&B Nucleic Acid Test
2019-nCoV/Flu A&B Nucleic Acid Test
2019-nCoV/Flu A&B Nucleic Acid Test
2019-nCoV/Flu A&B Nucleic Acid Test
2019-nCoV/Flu A&B Nucleic Acid Test
2019-nCoV/Flu A&B Nucleic Acid Test

编号 :

2019-nCoV/Flu A&B Nucleic Acid Test


国内外技术工艺

国内外技术工艺

保证质量

保证质量

量身定制

量身定制

原厂采购

原厂采购

SEO标签:

WhatsApp:

隐藏域元素占位

Detailed introduction


Sample type

Testing time

Limit of detection

Oropharyngeal swab

10~15min

2019-nCoV:1.5×102TCID50/mL

FluA:3.5×102TCID50/mL(A/悉尼/5/97(H3N2))

FluB:2.1×102TCID50/mL(B/山东/7/97)

Product Advantages:

1.Superior Methodology:Utilizes latex microsphere labeling technology for higher sensitivity and stronger protein-binding capacity.

2.User-Friendly Operation:No aliquot required for sample extraction buffer;Simplified processing with no instrumentation needed – results visible to the naked eye.

3.Multiplex Detection:Single-sample collection for simultaneous detection of three pathogens

Covers the most common causative agents of acute respiratory infections.

4.Rapid Testing:Results interpretable in 10–15 minutes.

5.High Specificity:Accurate results with no cross-reactivity from common clinical medications or other prevalent pathogens.

performance metrics:

A total of 633 samples were tested simultaneously with PCR assays. Among them:92 influenza A-positive samples showed a concordance rate of 66.3% (61/92);43 influenza B-positive samples demonstrated a concordance rate of 62.79% (27/43);213 novel coronavirus (COVID-19)-positive samples exhibited a concordance rate of 72.3% (154/213);285 negative samples achieved a concordance rate of 98.95% (282/285).The overall concordance rate across all samples was 82.78%.

 

Influenza A comparison results

 

Coei Reagent

PCR Reagent

Total

Positive

Negative

 Positive

61

0

61

Negative

31

282

313

Total

92

282

374

 

Influenza B comparison results

 

Coei Reagent

PCR Reagent

Total

Positive

Negative

 Positive

27

0

27

Negative

16

282

298

Total

43

282

325

 

COVID-19 comparison results

 

Coei Reagent

PCR Reagent

Total

Positive

Negative

 Positive

154

0

154

Negative

59

282

341

Total

213

282

495

Product Inquiry

Leave your phone number and we will contact you as soon as possible

Submit

*Note: Please fill in the information accurately and keep the communication open. We will contact you as soon as possible.

%E7%AC%AC%E4%B8%80%EF%BC%8C%E6%9C%80%EF%BC%8C%E4%BC%98%E7%A7%80%EF%BC%8C%E5%A2%9E%E5%BC%BA%EF%BC%8C%E4%B8%80%E6%B5%81%EF%BC%8C%E5%8D%93%E8%B6%8A%EF%BC%8C%E9%A2%86%E5%85%88%EF%BC%8C%E5%85%88%E8%BF%9B%EF%BC%8C%E5%BC%95%E9%A2%86

Sorry,当前栏目暂无内容!

您可以查看其他栏目或返回 首页

Sorry,The current column has no content!

You can view other columns or return Home